Britannia Life Sciences Inc.
BLAB
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.51M | -1.51M | -1.02M | 394.00K | 845.80K |
| Total Depreciation and Amortization | 115.60K | 115.60K | 126.10K | 140.20K | 151.60K |
| Total Amortization of Deferred Charges | 77.90K | 77.90K | 44.00K | 17.60K | -- |
| Total Other Non-Cash Items | 1.35M | 1.35M | 508.70K | -587.80K | -805.30K |
| Change in Net Operating Assets | 540.80K | 540.80K | 841.90K | 902.70K | 1.12M |
| Cash from Operations | 570.10K | 806.80K | 735.60K | 1.10M | 1.55M |
| Capital Expenditure | -12.60K | -12.60K | -8.30K | 78.30K | -92.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -687.00K | -687.00K | -812.60K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -192.80K | -192.80K | -136.60K | -88.20K | -26.90K |
| Cash from Investing | -205.40K | -336.70K | -963.20K | -828.20K | -1.06M |
| Total Debt Issued | 771.50K | 771.50K | 771.50K | -- | -- |
| Total Debt Repaid | -1.67M | -1.67M | -1.58M | -1.47M | -1.41M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -648.80K | -1.07M | -1.01M | -1.50M | -1.46M |
| Foreign Exchange rate Adjustments | 41.60K | 41.60K | 82.40K | -33.50K | 14.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -242.40K | -534.30K | -1.13M | -1.24M | -940.90K |